04051nam 2200949z- 450 991040409150332120231214132832.03-03928-713-3(CKB)4100000011302223(oapen)https://directory.doabooks.org/handle/20.500.12854/56130(EXLCZ)99410000001130222320202102d2020 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierPharmaceutical CrystalsMDPI - Multidisciplinary Digital Publishing Institute20201 electronic resource (148 p.)3-03928-712-5 The crystalline state is the most commonly used essential solid active pharmaceutical ingredient (API). The characterization of pharmaceutical crystals encompasses many scientific disciplines, but the core is crystal structure analysis, which reveals the molecular structure of essential pharmaceutical compounds. Crystal structure analysis provides important structural information related to the API's wide range of physicochemical properties, such as solubility, stability, tablet performance, color, and hygroscopicity. This book entitled “Pharmaceutical Crystals"" focuses on the relationship between crystal structure and physicochemical properties. In particular, the new crystal structure of pharmaceutical compounds involving multi-component crystals, such as co-crystals, salts, and hydrates, and polymorph crystals are reported. Such crystal structures were investigated in the latest studies that combined morphology, spectroscopic, theoretical calculation, and thermal analysis with crystallographic study. This book highlights the importance of crystal structure information in many areas of pharmaceutical science and presents current trends in the structure–property study of pharmaceutical crystals. The Guest Editors of this book hope the readers enjoy a wide variety of recent studies on Pharmaceutical Crystals.crystal structure analysisfamotidinesolution crystallizationsalt optimizationstructure determination from powder diffraction dataHirshfeld surface analysisDFTmolecular docking studymelting diagramdehydrationhygroscopicityHBVBenzodioxolepharmaceutical crystals4-b]indol-4-onepyrimidin-4(3H)-oneliquid assisted grindingHOMO-LUMOdissolutioncocrystal formationRaman spectroscopycarbamazepinehydrogen bonding3ondansetronphysicochemical propertiessolubilitysuccinic acidcocrystaladefovir dipivoxilhepatitis Bpolymorphshydrogen-bond-acceptance abilityDFT studyNitrofurantoin-4-dimethylaminopyridine (NF-DMAP) saltphotostabilityon-line monitoring5-dihydro-4H-pyrimido[5ImidazoleSemicarbazonecrystal habitCrystal structuresolvent-mediated polymorphic transformationticagrelorhydratepharmaceutical cocrystalmalonic acid1H-indolereactivity descriptorsfamoxadonecrystal structuredicarboxylic acidhydrogen bondsaccharinUekusa Hidehiroauth1297602Yonemochi EtsuoauthBOOK9910404091503321Pharmaceutical Crystals3024601UNINA